Choreo LLC Sells 129 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Choreo LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,309 shares of the financial services provider’s stock after selling 129 shares during the quarter. Choreo LLC’s holdings in iShares Biotechnology ETF were worth $437,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at $206,000. Prism Advisors Inc. purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $206,000. SeaCrest Wealth Management LLC increased its stake in iShares Biotechnology ETF by 203.7% during the 3rd quarter. SeaCrest Wealth Management LLC now owns 10,213 shares of the financial services provider’s stock valued at $1,487,000 after purchasing an additional 6,850 shares in the last quarter. SPC Financial Inc. increased its position in shares of iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after acquiring an additional 75 shares during the period. Finally, Good Life Advisors LLC grew its stake in iShares Biotechnology ETF by 59.4% during the 3rd quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock valued at $388,000 after purchasing an additional 993 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB opened at $135.47 on Thursday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm has a 50 day moving average of $135.88 and a two-hundred day moving average of $141.13.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.